Sector Alpha Week of 2026-07-31
Sector Alpha — machine-written from the numbers · Data as of 2026-07-31

Ambuja Cements Ltd

AMBUJACEM
Cement

Ambuja Cements Ltd is cheap for a reason. The P/E sits at the 26th percentile of its own range, and the quarters are still getting worse.

The sharpest disagreement: annual EPS moved +9.5% against a −28.9% price move — the market has not yet caught up with the delivery.

The price is in a downtrend (35 weeks in) while the P/E sits at the 26th percentile of its own 10-year range. Underneath, the last four quarters read deteriorating — profit −36.6% year on year, and 85% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.

Stage
Mixed
partial read
Price
₹432
−28.9% 1Y
P/E
22.8×
26th pctile
of its own 10-year range
Revenue (Jun 26)
₹9,500 Cr
−7.7% YoY
Profit (Jun 26)
₹660 Cr
−36.6% YoY
Operating margin
17.0%
−2.0 pp YoY
ROCE
6%
Mar 26
Cash conversion
85%
of profit, last 3 FY
Withheld from this page: Part of this page is deliberately not drawn: its two data sources disagree by up to 49% on reported income across 14 comparable periods, so nothing from the second source is placed here — the PEG ratio and its quarterly curve, the quarterly return curves, the annual return-on-invested-capital overlay, the total-debt and debt-to-equity series and the F-score and the return-on-invested-capital reading are absent for that reason. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data. The quarterly history also begins where the primary source begins: 6 earlier quarters the second source carries are not spliced in front of it. Extending a reported profit series is stricter than showing a ratio chart — it needs a source that has been checked.
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Ambuja Cements Ltd trades at ₹432, in a downtrend and 35 weeks into that stage. That is −9.2% against its own 200-day average. It sits at 13% of a 52-week range of ₹409 to ₹582. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (34 weeks and counting).

Today the stock is in a downtrend — week 35 of stage 4, confirmed. At ₹432 it trades −9.2% versus its 200-day average and sits at 13% of its 52-week range (₹409–₹582).

Jul 26: ₹432 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−9.2% versus the 200-day line, week 35 of stage 4
Price50-day avg200-day avg
S2S2S4S2S4₹709₹628₹548₹467₹387₹432₹476Jul 23May 24Feb 25Nov 25Jul 26
S2S2S4S2S4₹709₹628₹548₹467₹387₹432₹476Jul 23Feb 25Jul 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (549 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Mar 16Jul 26

Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +115% while the NIFTY 500 moved +276% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (34 weeks and counting; last ahead the week of 2026-01-16) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Ambuja Cements Ltd trades at 22.8× P/E, near the bottom of its own range — cheaper only 26% of the time. Its long-run median P/E is 27.8×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 22.8× is near the bottom of its own range — cheaper only 26% of the time, against a long-run median of 27.8× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 22.8× vs a 27.8× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 10.4-year window; loss-period spikes above 55× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
near the bottom of its own range — cheaper only 26% of the time
P/EMedianEPS (TTM) (quarterly)
58.1×₹25.846.5×₹19.435.0×₹12.923.5×₹6.511.9×₹0.0×22.70×₹19Mar 16Oct 18Jun 21Jan 24Jul 26
58.1×₹25.846.5×₹19.435.0×₹12.923.5×₹6.511.9×₹0.0×22.70×₹19Mar 16Jun 21Jul 26
P/E
22.8×
26th percentile of 10y

Why the multiple sits where it does: over the past year annual EPS moved +9.5% against a −28.9% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 5y, of the +1.0%/yr price move, ~+2.9%/yr came from earnings growth and ~−1.9 pp from the multiple (compressing); over 10y, of the +4.8%/yr price move, ~+9.5%/yr came from earnings growth and ~−4.7 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.

The PEG ratio and its quarterly curve, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 49% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

03 · Stage: Mixed

Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Ambuja Cements Ltd reads as mixed on its fundamental arc. Mixed — profit and EPS growth are shrinking while ROCE is still lifting at 17.0% — falling growth against firm returns, so no single stage word fits yet. The read is built from 8 quarters across 4 curves, on partial evidence.

Growth, year by year: revenue +15.1% in Mar 26, profit +6.5% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
123%87%86%52%49%16%12%−20%−25%−56%%%15.1%6.5%FY15FY20Mar 26
123%87%86%52%49%16%12%−20%−25%−56%%%15.1%6.5%FY15FY20Mar 26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue rolling over, profit rolling over
RevenueProfitEPS
19%97%15%68%10%38%6.1%8.7%1.8%−21%%%7.1%−5.9%−3.1%Sep 23Dec 24Jun 26
19%97%15%68%10%38%6.1%8.7%1.8%−21%%%7.1%−5.9%−3.1%Sep 23Dec 24Jun 26
ROCE Annual readings — the quarterly balance-sheet pieces this curve needs are not held for this stock, so the returns read moves once a year and carries less weight in the call.
the return curve, annual readings
ROCE
17%16%15%13%12%%17%FY18FY19FY21
17%16%15%13%12%%17%FY18FY19FY21
Revenue growth
Steady high
latest +7.1% · span +3.0% to +17.9%
Profit growth
Falling
latest −5.9% · span −6.7% to +89.1%
EPS growth
Falling
latest −3.1% · span −12.7% to +75.0%
ROCE
Rising
latest 17.0% · span 12.0%–17.0%

Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+15.1%+1.5%+7.0%+7.3%
Profit+6.5%+23.1%+8.7%+14.7%
EPS+9.5%+13.7%+6.4%+13.1%
Share price−28.9%−1.7%+1.0%+4.8%
Revenue YoY (Jun 26)
−7.7%
latest quarter vs a year ago
Profit YoY (Jun 26)
−36.6%
latest quarter vs a year ago
Revenue 10y
14.2%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

38.9/100 — rank 21 of 26 in Cement · 82% evidence confidence

Ambuja Cements Ltd scores 38.9 out of 100 against the 26 companies it is compared with in Cement, ranking 21. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 9.4 + 11 + 12.6 + 5.9 = 38.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Ambuja Cements Ltd reported ₹9,500 Cr of revenue in the Jun 26 quarter, −7.7% year on year. Over 11 years it has compounded at 14.2% a year. The last full year, Mar 26, came in at ₹40,656 Cr. The last four reported quarters add to ₹39,867 Cr.

Mar 26 revenue came in at ₹40,656 Cr (+15.1% on the year), capping 11 years at 14.2% compound. The latest quarter (Jun 26) printed ₹9,500 Cr, −7.7% year on year.

Mar 26 revenue ₹40,656 Cr (+15.1% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
14.2% a year over 11 years
RevenueYoY growth
43.9k123%32.9k86%22.0k49%11.0k12%0−25%₹ Cr%₹40,65615.1%FY15FY20Mar 26
43.9k123%32.9k86%22.0k49%11.0k12%0−25%₹ Cr%₹40,65615.1%FY15FY20Mar 26
Jun 26: ₹9,500 Cr (−7.7% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Revenue (quarterly)YoY growth
11.8k25%8.8k16%5.9k7.4%2.9k−1.3%0−10%₹ Cr%₹9,500−7.7%Sep 23Dec 24Jun 26
11.8k25%8.8k16%5.9k7.4%2.9k−1.3%0−10%₹ Cr%₹9,500−7.7%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged +8.1% growth against the decade's 14.2% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +7.1% over the last 4 quarters against +10.2%/yr over the last 8 — rolling over; TTM profit −5.9% vs +9.2%/yr — rolling over.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Ambuja Cements Ltd's operating margin is 17.0% in the Jun 26 quarter, −2.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 13.0% to 21.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 17.0%, −2.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 13.0%–21.0%.

🚨 Why the margin moved: operating margin went −2.3 pp year on year while gross margin went −0.5 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

Mar 26: 16.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a 13.0–21.0% band over 13 years
operating marginYoY change (pp)
22%7.1%19%3.1%17%−1.0%15%−5.1%12%−9.1%%%16%−1%FY13FY19Mar 26
22%7.1%19%3.1%17%−1.0%15%−5.1%12%−9.1%%%16%−1%FY13FY19Mar 26
Jun 26: 17.0% operating margin (−2.0 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
22%9.1%19%5.1%17%1.0%15%−3.1%12%−7.1%%%17%−2%Sep 23Dec 24Jun 26
22%9.1%19%5.1%17%1.0%15%−3.1%12%−7.1%%%17%−2%Sep 23Dec 24Jun 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Ambuja Cements Ltd earned ₹660 Cr of net profit in the Jun 26 quarter, −36.6% year on year. Full-year Mar 26 profit was ₹5,637 Cr. The 11-year compound rate is 19.3%. That is 6.9% of the quarter's revenue. The same quarter a year earlier earned ₹1,041 Cr.

Jun 26 profit was ₹660 Cr, −36.6% year on year. On the full year, Mar 26 printed ₹5,637 Cr (+6.5%), and the 11-year compound rate is 19.3%.

Mar 26 profit ₹5,637 Cr (+6.5% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
19.3% a year over 11 years
Net profitYoY growth
6.1k87%4.6k52%3.0k16%1.5k−20%0−56%₹ Cr%₹5,6376.5%FY15FY20Mar 26
6.1k87%4.6k52%3.0k16%1.5k−20%0−56%₹ Cr%₹5,6376.5%FY15FY20Mar 26
Jun 26: ₹660 Cr (−36.6% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
2.9k400%2.2k270%1.4k140%7199.4%0−121%₹ Cr%₹660−36.6%Sep 23Dec 24Jun 26
2.9k400%2.2k270%1.4k140%7199.4%0−121%₹ Cr%₹660−36.6%Sep 23Dec 24Jun 26

🚨 Why profit moved: revenue contributed −7.7% and the margin −2.0 pp — the quarter was revenue-led despite a thinner margin.

Pace comparison, last four quarters: profit +70.0% vs revenue +8.1%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 85% of Ambuja Cements Ltd's reported profit arrived as operating cash — the cash follows the profit. In Mar 26 that was ₹5,362 Cr of operating cash against ₹5,637 Cr of profit. After ₹18,330 Cr of capital spending, ₹−12,968 Cr was left as free cash.

Mar 26: operating cash of ₹5,362 Cr against reported profit of ₹5,637 Cr, leaving free cash of ₹−12,968 Cr after ₹18,330 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 85% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

Mar 26: CFO ₹5,362 Cr vs profit ₹5,637 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution. FY16/Mar 25 reflects an acquisition year — point shown clipped.
85% of 3-year profit arrived as cash
Operating cashNet profitFree cash
7.1k1.7k−3.7k−9.1k−14.5k₹ Cr₹5,362₹5,637₹−12,968FY15FY20Mar 26
7.1k1.7k−3.7k−9.1k−14.5k₹ Cr₹5,362₹5,637₹−12,968FY15FY20Mar 26
Mar 26: CFO = 95% of profit (three-year rate 85%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash.
Conversion100%
210%160%110%60%10%%95%FY15FY20Mar 26
210%160%110%60%10%%95%FY15FY20Mar 26

Why conversion sits at 85%: the cash cycle stretched 95 days between FY20 and Mar 26 — more of each rupee of profit waits inside the cycle before arriving.

Router verdict: the bigger cash user is investment — capital spending ran 6.5× depreciation over three years, so the next section's job is to check what that build-out is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Ambuja Cements Ltd's cash conversion cycle runs 37 days in Mar 26, up from −58 days in FY20. Capital spending ran ₹48,802 Cr over the last 3 years. At Mar 26 sales of ₹40,656 Cr each day of that cycle holds about ₹111 Cr, so roughly ₹4,121 Cr sits inside the business at any moment.

Mar 26: debtors at 17 days, inventory at 246 days — roughly 8.1 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 37 days, looser than FY20's −58.

The full loop: cash goes out to suppliers and production on day 0; stock waits 246 days to sell; customers pay about 17 days after that; and suppliers themselves are paid at 227 days — netting out to the 37-day cycle.

In money terms: at Mar 26 sales of ₹40,656 Cr, each day of the cycle holds about ₹111 Cr — so the 37-day loop keeps roughly ₹4,121 Cr sitting inside the business at any moment.

Mar 26: a 37-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 13-year window.
+95 days vs FY20
Cash cycleInventory daysDebtor daysPayable days
45731918142−96days37d246d17d227dFY13FY16FY19Mar 23Mar 26
45731918142−96days37d246d17d227dFY13FY19Mar 26

On the investment side: capital spending of ₹48,802 Cr over the last 3 fiscal years against ₹7,495 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹9,121 Cr (Mar 26) — capacity paid for but not yet earning.

Mar 26: capex ₹18,330 Cr, work-in-progress ₹9,121 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
a build-out
CapexWork-in-progress
21.7k16.3k10.8k5.4k0₹ Cr₹18,330₹9,121FY14FY16FY19FY21Mar 26
21.7k16.3k10.8k5.4k0₹ Cr₹18,330₹9,121FY14FY19Mar 26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

Ambuja Cements Ltd earns a ROCE of 6% in Mar 26. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 13.9% net margin on 0.45× asset turns.

Mar 26 ROCE is 6%.

Why the return is what it is — the wiring (Mar 26): 13.9% net margin × 0.45× asset turns × 1.51× balance-sheet leverage ≈ 9.4% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

Mar 26: ROCE 6% Return on capital employed by fiscal year, % (line). 13-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the full ladder
ROCEWACC
19%15%12%8.5%5.0%%6%FY13FY16FY19Mar 23Mar 26
19%15%12%8.5%5.0%%6%FY13FY19Mar 26

The quarterly return curves and the return-on-invested-capital overlay, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 49% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.

Ambuja Cements Ltd carries ₹866 Cr of borrowings against ₹59,347 Cr of equity in Mar 26, a debt-to-equity of 0.01. Operating profit covers the interest bill 29×. Over 6 years borrowings went from ₹471 Cr to ₹866 Cr. Capital spending ran ₹48,802 Cr across the last 3 of those years.

Mar 26: borrowings of ₹866 Cr against equity of ₹59,347 Cr — a debt-to-equity of 0.01. Operating profit covers the interest bill 29×. Over 6 years borrowings went from ₹471 Cr to ₹866 Cr while capital spending ran ₹48,802 Cr in just the last 3 — part of the build-out is riding on borrowed money.

Mar 26: borrowings ₹866 Cr at 0.01× equity Borrowings by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 13-year window. Quarterly balance-sheet history is not held for India — annual is the honest resolution.
the debt trajectory
BorrowingsDebt-to-equity
9350.022×7010.016×4680.010×2340.004×0−0.002×₹ Cr×₹8660.01×FY13FY16FY19Mar 23Mar 26
9350.022×7010.016×4680.010×2340.004×0−0.002×₹ Cr×₹8660.01×FY13FY19Mar 26

The total-debt and debt-to-equity series, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 49% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Foreign institutions cut 5.0 points of Ambuja Cements Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 5.6% of the company. Domestic institutions moved +4.5 points over the same window, to 19.4%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Foreign institutions: −5.0 points over 8 quarters to 5.6%; Domestic institutions: +4.5 points over 8 quarters to 19.4%; Promoters: −0.2 points over 8 quarters to 67.3%.

Why the register moved: rotation — foreign institutions −5.0 points against domestic institutions +4.5 points over 8 quarters, with promoters holding steady — one class of institutions handing the register to the other, not a verdict change by the people closest to the numbers.

Fiscal-year ends: promoters +0.9 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
73%55%37%19%0.9%%67.7%5.9%19.9%6.4%Mar 24Mar 25Mar 26
73%55%37%19%0.9%%67.7%5.9%19.9%6.4%Mar 24Mar 25Mar 26
Foreign institutions cut 5.0 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
76%57%38%19%0.0%%67.3%5.6%19.4%7.4%Sep 23Mar 25Jun 26
76%57%38%19%0.0%%67.3%5.6%19.4%7.4%Sep 23Mar 25Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Ambuja Cements Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · Cement
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Star Cement LtdSTARCEMENT 76.0/100Favorable setup90% evidence ASLEEP 29.9/35 Revenue 19.4% · PAT 100% · OPM change 2 pp 88% evidence 22.4/25 ROCE 16.7% · OPM 27% 100% evidence 11.3/20 P/E 20.4× · PEG 1.11 100% evidence 12.4/20 RS sector 13.8% · RS bench -13.2% · 1Y -12.5%1 of 10 weeks ahead 70% evidence
Exact sum: 29.9 + 22.4 + 11.3 + 12.4 = 76 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
2NCL Industries LtdNCLIND 69.7/100Favorable setup83% evidence FADING 25.3/35 Revenue 1.8% · PAT 100% · OPM change 7 pp 83% evidence 18.0/25 ROCE 14.5% · OPM 13% 95% evidence 15.0/20 P/E 6.3× · PEG — 50% evidence 11.4/20 RS sector 2.1% · RS bench -6.3% · 1Y -18.8%2 of 12 weeks ahead 100% evidence
Exact sum: 25.3 + 18 + 15 + 11.4 = 69.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
3UltraTech Cement LtdULTRACEMCO 63.1/100Mixed-positive evidence76% evidence TURNING 21.9/35 Revenue 17.2% · PAT 26.7% · OPM change -1 pp 95% evidence 17.1/25 ROCE 12.7% · OPM 20% 76% evidence 9.2/20 P/E 40.7× · PEG — 50% evidence 14.9/20 RS sector 17% · RS bench -1.4% · 1Y -2.8%0 of 10 weeks ahead 70% evidence
Exact sum: 21.9 + 17.1 + 9.2 + 14.9 = 63.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Mangalam Cement LtdMANGLMCEM 62.9/100Mixed-positive evidence96% evidence FADING 21.6/35 Revenue 4.6% · PAT 100% · OPM change 0 pp 88% evidence 11.7/25 ROCE 11% · OPM 11% 100% evidence 16.0/20 P/E 17.5× · PEG 0.6 100% evidence 13.6/20 RS sector 24.1% · RS bench 14.9% · 1Y 31.3%5 of 12 weeks ahead 100% evidence
Exact sum: 21.6 + 11.7 + 16 + 13.6 = 62.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Rain Industries LtdRAIN 62.5/100Mixed-positive evidence64% evidence BREAKING OUT 22.9/35 Revenue 14.4% · PAT 100% · OPM change 5 pp 62% evidence 9.4/25 ROCE 8.3% · OPM 15% 76% evidence 10.2/20 P/E 24.9× · PEG — 15% evidence 20.0/20 RS sector 61.8% · RS bench 49.7% · 1Y 43.6%12 of 12 weeks ahead 100% evidence
Exact sum: 22.9 + 9.4 + 10.2 + 20 = 62.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Orient Cement LtdORIENTCEM 58.2/100Mixed-positive evidence93% evidence ASLEEP 17.6/35 Revenue -12.1% · PAT -19.3% · OPM change 3 pp 100% evidence 16.9/25 ROCE 16.5% · OPM 24% 100% evidence 16.1/20 P/E 13.2× · PEG 0.25 65% evidence 7.6/20 RS sector -12% · RS bench -20.1% · 1Y -45.9%0 of 12 weeks ahead 100% evidence
Exact sum: 17.6 + 16.9 + 16.1 + 7.6 = 58.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7Dalmia Bharat LtdDALBHARAT 53.4/100Mixed-positive evidence94% evidence ASLEEP 13.0/35 Revenue 7.6% · PAT 0.4% · OPM change -3 pp 100% evidence 12.8/25 ROCE 7.6% · OPM 21% 100% evidence 15.3/20 P/E 30.7× · PEG 0.72 100% evidence 12.3/20 RS sector 12.6% · RS bench -11.9% · 1Y -19.3%0 of 10 weeks ahead 70% evidence
Exact sum: 13 + 12.8 + 15.3 + 12.3 = 53.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
8Shree Cement LtdSHREECEM 51.8/100Mixed-positive evidence97% evidence BREAKING OUT 15.0/35 Revenue 12.6% · PAT 9.9% · OPM change -5 pp 95% evidence 13.0/25 ROCE 10.3% · OPM 20% 95% evidence 9.2/20 P/E 57.7× · PEG 0.96 100% evidence 14.6/20 RS sector 5.1% · RS bench -3.7% · 1Y -15.8%3 of 12 weeks ahead 100% evidence
Exact sum: 15 + 13 + 9.2 + 14.6 = 51.8 · Decision use: Price leads the evidence: RS versus the benchmark is -3.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
9JSW Cement LtdJSWCEMENT 50.8/100Thin evidence · provisional51% evidence TURNING 18.6/35 Revenue 12% · PAT -80% · OPM change 5 pp 83% evidence 12.1/25 ROCE 11.1% · OPM 19% 76% evidence 10.1/20 P/E 27.8× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y -8.9%5 of 10 weeks ahead 0% evidence
Exact sum: 18.6 + 12.1 + 10.1 + 10 = 50.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
10K C P LtdKCP 49.4/100Mixed-negative evidence77% evidence ASLEEP 13.5/35 Revenue 1.9% · PAT 8.7% · OPM change 1 pp 83% evidence 16.1/25 ROCE 12.2% · OPM 17% 95% evidence 13.9/20 P/E 10.3× · PEG — 50% evidence 5.9/20 RS sector -14% · RS bench -9.4% · 1Y -23.5%3 of 11 weeks ahead 70% evidence
Exact sum: 13.5 + 16.1 + 13.9 + 5.9 = 49.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
11HeidelbergCement India LtdHEIDELBERG 48.6/100Mixed-negative evidence100% evidence ASLEEP 14.5/35 Revenue 6.6% · PAT 2.6% · OPM change -4 pp 100% evidence 14.7/25 ROCE 14.7% · OPM 11% 100% evidence 13.7/20 P/E 28.5× · PEG 0.82 100% evidence 5.7/20 RS sector -5.1% · RS bench -13.3% · 1Y -28.1%0 of 12 weeks ahead 100% evidence
Exact sum: 14.5 + 14.7 + 13.7 + 5.7 = 48.6 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
12J K Cements LtdJKCEMENT 48.1/100Mixed-negative evidence94% evidence TURNING 11.2/35 Revenue 15.9% · PAT -7.1% · OPM change -5 pp 100% evidence 16.4/25 ROCE 15.1% · OPM 16% 100% evidence 8.1/20 P/E 43.1× · PEG 1.46 100% evidence 12.4/20 RS sector 10.4% · RS bench -7.1% · 1Y -16%0 of 10 weeks ahead 70% evidence
Exact sum: 11.2 + 16.4 + 8.1 + 12.4 = 48.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13The Ramco Cements LtdRAMCOCEM 47.3/100Mixed-negative evidence90% evidence ASLEEP 20.6/35 Revenue 6% · PAT 100% · OPM change 1 pp 88% evidence 13.2/25 ROCE 6.1% · OPM 14% 100% evidence 1.2/20 P/E 732× · PEG 4.14 100% evidence 12.3/20 RS sector 11.1% · RS bench -10.1% · 1Y -19.7%0 of 10 weeks ahead 70% evidence
Exact sum: 20.6 + 13.2 + 1.2 + 12.3 = 47.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14JK Lakshmi Cement LtdJKLAKSHMI 47.3/100Mixed-negative evidence65% evidence ASLEEP 17.4/35 Revenue 9.2% · PAT 49.6% · OPM change -5 pp 83% evidence 13.9/25 ROCE 12% · OPM 14% 76% evidence 10.6/20 P/E 17.6× · PEG — 15% evidence 5.4/20 RS sector -8.2% · RS bench -23.6% · 1Y -40.3%0 of 10 weeks ahead 70% evidence
Exact sum: 17.4 + 13.9 + 10.6 + 5.4 = 47.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Nuvoco Vistas Corporation LtdNUVOCO 47.1/100Mixed-negative evidence87% evidence TURNING 21.0/35 Revenue 9.5% · PAT 100% · OPM change 0 pp 100% evidence 9.6/25 ROCE 7.1% · OPM 18% 100% evidence 4.8/20 P/E 29.7× · PEG 8.14 65% evidence 11.7/20 RS sector 3.6% · RS bench -5% · 1Y -16.5%4 of 10 weeks ahead 70% evidence
Exact sum: 21 + 9.6 + 4.8 + 11.7 = 47.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16India Cements LtdINDIACEM 45.4/100Mixed-negative evidence75% evidence ASLEEP 21.3/35 Revenue 7% · PAT 100% · OPM change 7 pp 74% evidence 3.8/25 ROCE 1.2% · OPM 15% 100% evidence 5.4/20 P/E 91.4× · PEG — 50% evidence 14.9/20 RS sector 20% · RS bench -2% · 1Y 10.8%0 of 10 weeks ahead 70% evidence
Exact sum: 21.3 + 3.8 + 5.4 + 14.9 = 45.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17Deccan Cements LtdDECCANCE 43.7/100Mixed-negative evidence70% evidence ASLEEP 22.6/35 Revenue 20.6% · PAT 100% · OPM change -3 pp 83% evidence 7.9/25 ROCE 3.3% · OPM 8.1% 95% evidence 9.1/20 P/E 43.4× · PEG — 15% evidence 4.1/20 RS sector -12.9% · RS bench -29.1% · 1Y -47.7%0 of 10 weeks ahead 70% evidence
Exact sum: 22.6 + 7.9 + 9.1 + 4.1 = 43.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18ACC LtdACC 42.5/100Mixed-negative evidence94% evidence ASLEEP 9.1/35 Revenue 11.6% · PAT -21.1% · OPM change -5 pp 100% evidence 9.9/25 ROCE 11.2% · OPM 8% 100% evidence 16.7/20 P/E 13.4× · PEG 0.92 100% evidence 6.8/20 RS sector -6.7% · RS bench -16.8% · 1Y -26.5%0 of 10 weeks ahead 70% evidence
Exact sum: 9.1 + 9.9 + 16.7 + 6.8 = 42.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
19Birla Corporation LtdBIRLACORPN 41.0/100Mixed-negative evidence94% evidence ASLEEP 17.4/35 Revenue 3.9% · PAT 44.6% · OPM change -1 pp 100% evidence 10.4/25 ROCE 9.8% · OPM 13% 100% evidence 8.8/20 P/E 12.3× · PEG 3.92 100% evidence 4.4/20 RS sector -14% · RS bench -17.4% · 1Y -37.4%3 of 9 weeks ahead 70% evidence
Exact sum: 17.4 + 10.4 + 8.8 + 4.4 = 41 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20Sagar Cements LtdSAGCEM 41.0/100Mixed-negative evidence66% evidence ASLEEP 19.5/35 Revenue 13.4% · PAT 79.7% · OPM change -8 pp 95% evidence 5.1/25 ROCE 2% · OPM 10% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 6.4/20 RS sector -8.1% · RS bench -16.3% · 1Y -28.1%0 of 10 weeks ahead 70% evidence
Exact sum: 19.5 + 5.1 + 10 + 6.4 = 41 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21Ambuja Cements Ltdthis pageAMBUJACEM 38.9/100Mixed-negative evidence82% evidence ASLEEP 9.4/35 Revenue 7.1% · PAT -5.9% · OPM change -2 pp 95% evidence 11.0/25 ROCE 5.6% · OPM 17% 76% evidence 12.6/20 P/E 22.8× · PEG — 50% evidence 5.9/20 RS sector -7.2% · RS bench -15.1% · 1Y -29.5%0 of 12 weeks ahead 100% evidence
Exact sum: 9.4 + 11 + 12.6 + 5.9 = 38.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Saurashtra Cement LtdSAURASHCEM 38.8/100Mixed-negative evidence76% evidence ASLEEP 19.7/35 Revenue 8.4% · PAT 87.5% · OPM change -5 pp 83% evidence 4.8/25 ROCE 2.5% · OPM 6% 95% evidence 9.5/20 P/E 30.9× · PEG — 15% evidence 4.8/20 RS sector -16.6% · RS bench -24.6% · 1Y -41.9%0 of 12 weeks ahead 100% evidence
Exact sum: 19.7 + 4.8 + 9.5 + 4.8 = 38.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23Prism Johnson LtdPRSMJOHNSN 38.2/100Mixed-negative evidence69% evidence ASLEEP 12.1/35 Revenue 6.3% · PAT -33.3% · OPM change -2 pp 83% evidence 5.9/25 ROCE 5.9% · OPM 8% 76% evidence 8.6/20 P/E — · PEG — 35% evidence 11.6/20 RS sector 14.3% · RS bench -20.9% · 1Y -32.2%1 of 10 weeks ahead 70% evidence
Exact sum: 12.1 + 5.9 + 8.6 + 11.6 = 38.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
24BIGBLOC Construction LtdBIGBLOC 36.7/100Thin evidence · provisional59% evidence ASLEEP 15.4/35 Revenue 26.2% · PAT -80% · OPM change -1.6 pp 62% evidence 5.8/25 ROCE 1.8% · OPM 7.3% 95% evidence 10.0/20 P/E — · PEG — 0% evidence 5.5/20 RS sector -9.7% · RS bench -17.9% · 1Y -24.7%3 of 10 weeks ahead 70% evidence
Exact sum: 15.4 + 5.8 + 10 + 5.5 = 36.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
25Shree Digvijay Cement Co. LtdSHREDIGCEM 31.2/100Adverse evidence81% evidence ASLEEP 10.8/35 Revenue 19.6% · PAT -35% · OPM change -3.5 pp 95% evidence 8.2/25 ROCE 6.4% · OPM 8.7% 95% evidence 6.1/20 P/E 59.4× · PEG — 50% evidence 6.1/20 RS sector -12.4% · RS bench -10.9% · 1Y -15.8%4 of 10 weeks ahead 70% evidence
Exact sum: 10.8 + 8.2 + 6.1 + 6.1 = 31.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Shiva Cement LtdSHIVACEM 36.5/100Thin evidence · provisional42% evidence 18.1/35 Revenue 19.7% · PAT -47.1% · OPM change 15 pp 40% evidence 5.4/25 ROCE -3% · OPM 1% 57% evidence 10.0/20 P/E — · PEG — 0% evidence 3.0/20 RS sector -27.5% · RS bench -36.4% · 1Y -54.1%0 of 12 weeks ahead to 2026-03-08 70% evidence
Exact sum: 18.1 + 5.4 + 10 + 3 = 36.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is Ambuja Cements Ltd's share price today?

Ambuja Cements Ltd trades at ₹432, −28.9% over the past year. The company is valued at ₹1,07,394 Cr. The stock sits at 13% of its 52-week range of ₹409–₹582, −9.2% versus its 200-day average. On the tape, the price is in a downtrend, 35 weeks in. — as of 31 July 2026.

What were Ambuja Cements Ltd's latest quarterly results?

Ambuja Cements Ltd reported revenue of ₹9,500 Cr and net profit of ₹660 Cr for the Jun 26 quarter. Revenue fell 7.7% and profit fell 36.6% year on year. Earnings per share were ₹2.32. The operating margin was 17.0%, 2.0 pp lower than a year earlier. — as of 31 July 2026.

What is Ambuja Cements Ltd's revenue?

Ambuja Cements Ltd reported revenue of ₹9,500 Cr in the Jun 26 quarter, −7.7% year on year. For the full Mar 26 fiscal year, revenue was ₹40,656 Cr (+15.1%). Over the last 11 years revenue compounded at 14.2% a year. — as of 31 July 2026.

What is Ambuja Cements Ltd's profit?

Ambuja Cements Ltd earned ₹660 Cr of net profit in the Jun 26 quarter, −36.6% year on year. Full-year Mar 26 profit was ₹5,637 Cr. The operating margin ran 17.0% in the latest quarter. — as of 31 July 2026.

What is Ambuja Cements Ltd's market cap?

Ambuja Cements Ltd's market capitalisation is ₹1,07,394 Cr at a share price of ₹432. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.

What is Ambuja Cements Ltd's P/E ratio?

Ambuja Cements Ltd trades at a P/E of 22.8×, at the 26th percentile of its own 10-year range, against a long-run median of 27.8×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.

Does Ambuja Cements Ltd pay a dividend?

Yes — Ambuja Cements Ltd's dividend payout was 10% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.

Is Ambuja Cements Ltd overvalued?

On its own history, Ambuja Cements Ltd looks cheap against its own history: its P/E of 22.8× has been cheaper only 26% of the time in 10 years (long-run median 27.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.

Is Ambuja Cements Ltd growing?

Not right now — Ambuja Cements Ltd's latest numbers are shrinking: latest-quarter revenue −7.7% year on year, profit −36.6%, and the margin −2.0 pp at 17.0%. The 11-year compound rates are 14.2% (revenue) and 19.3% (profit). The earnings engine currently reads: deteriorating — as of 31 July 2026.

How is Ambuja Cements Ltd performing?

Ambuja Cements Ltd is in a downtrend, 35 weeks in. Its latest quarter's revenue fell 7.7% and profit fell 36.6% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 34 weeks. This describes what the data did, not a rating. — as of 31 July 2026.

What stage is Ambuja Cements Ltd in?

Mixed — profit and EPS growth are shrinking while ROCE is still lifting at 17.0% — falling growth against firm returns, so no single stage word fits yet. The read comes from the last 12 quarters of growth (revenue growth +7.1% latest, profit growth −5.9% latest, eps growth −3.1% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.

Is Ambuja Cements Ltd in an uptrend?

No — the price is in a downtrend (week 35 of stage 4), trading −9.2% versus its 200-day average and at 13% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.

Is Ambuja Cements Ltd beating the market?

Not lately — on a trailing-13-week view Ambuja Cements Ltd is currently behind the NIFTY 500 (34 weeks and counting; last ahead the week of 2026-01-16), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +115% against the NIFTY 500's +276% — behind the index over the full window. — as of 31 July 2026.

Will Ambuja Cements Ltd's share price go up?

This page publishes no price forecast for Ambuja Cements Ltd. What it measures instead: the share price is ₹432, the price is in a downtrend 35 weeks in. Its P/E of 22.8× sits at the 26th percentile of its own 10-year range. — as of 31 July 2026.

Who owns Ambuja Cements Ltd?

Promoters hold 67.3% of Ambuja Cements Ltd, foreign institutions 5.6%, domestic institutions 19.4% and the public 7.4% (latest quarter). The biggest move on the register over the last two years: Foreign institutions cut 5.0 points over 8 quarters. — as of 31 July 2026.

Does Ambuja Cements Ltd have too much debt?

No — Ambuja Cements Ltd's debt-to-equity is 0.01, and operating profit covers the interest bill 29×. Mar 26 borrowings were ₹866 Cr against equity of ₹59,347 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.

What is Ambuja Cements Ltd's capex?

Ambuja Cements Ltd spent ₹48,802 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In Mar 26 alone that was ₹18,330 Cr, with ₹9,121 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.

What is Ambuja Cements Ltd's cash flow?

Ambuja Cements Ltd generated ₹5,362 Cr of operating cash flow in Mar 26 and ₹−12,968 Cr of free cash flow after ₹18,330 Cr of capital spending. Reported profit that year was ₹5,637 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 31 July 2026.

Is Ambuja Cements Ltd's profit real cash?

Yes — over the last 3 fiscal years, 85% of Ambuja Cements Ltd's reported profit arrived as operating cash. In Mar 26, operating cash was ₹5,362 Cr against reported profit of ₹5,637 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 31 July 2026.

Where is Ambuja Cements Ltd in its business cycle?

Ambuja Cements Ltd's Mar 26 operating margin was 16.0%, against a 13-year band of 13.0%–21.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 17.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.

What could break the Ambuja Cements Ltd story?

The sharpest disagreement: annual EPS moved +9.5% against a −28.9% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.

Is Ambuja Cements Ltd a stock worth studying right now?

This is not investment advice. The machine read: Ambuja Cements Ltd is cheap for a reason. The P/E sits at the 26th percentile of its own range, and the quarters are still getting worse. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI